CD146 gene expression in clear cell renal cell carcinoma: A potential marker for prediction of early recurrence after nephrectomy

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1663-1669

  Feng, Gang ^a   Fang, Fang ^a   Liu, Chunsheng ^a   Zhang, Fan ^a   Huang, Houbao ^a   Pu, Chun ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

CD146 gene expression; Clear cell renal cell carcinoma; Early recurrence; Predict marker

Indexed keywords

CD146 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CD146 GENE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC RISK; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION; TUMOR BIOPSY; TUMOR VOLUME; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MIDDLE AGED; PROGNOSIS; TIME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD146; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; TIME FACTORS;

EID: 84877592121     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0255-4     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
2. Lam JS, Leppert JT, Belldegrun AS, et al. (2005) Novel approaches in the therapy of metastatic renal cell carcinoma. World J Urol 23:202-212
3. Klatte T, Seligson DB, LaRochelle J, et al. (2009) Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 18:894-900
4. Sharma SG, Aggarwal N, Gupta SD, et al. (2011) Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol 43:125-129
5. Fan F, Schimming A, Jaeger D, et al. (2012) Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012:281261
6. Lehmann JM, Riethmüller G, Johnson JP (1989) MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci U S A 86:9891-9895
7. Bardin N, Frances V, Lesaule G, et al. (1996) Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 218:210-216
8. Bardin N, Anfosso F, Masse JM, et al. (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98:3677-3684
9. Zheng C, Qiu Y, Zeng Q, et al. (2009) Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J Biochem Cell Biol 41:2163-2172
10. Wu GJ, Fu P, Chiang CF, et al. (2005) Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urol 173:1778-1783
11. Aldovini D, Demichelis F, Doglioni C, et al. (2006) M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer 119:1920-1926
12. Zabouo G, Imbert AM, Jacquemier J, et al. (2009) CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res 11:R1
13. Finley DS, Pantuck AJ, Belldegrun AS, et al. (2011) Tumor biology and prognostic factors in renal cell carcinoma. Oncologist 16:4-13
14. Li G, Feng G, Gentil-Perret A, et al. (2008) Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol 180:513-514
15. Phuoc NB, Ehara H, Gotoh T, et al. (2008) Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Oncol Rep 20:525-530
16. Dirim A, Haberal AN, Goren MR, et al. (2008) VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value. Int Urol Nephrol 40:861-868
17. Dolley-Hitze T, Jouan F, Martin B, et al. (2010) Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? Br J Cancer 103:1698-1705
18. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118-132
19. Ostmeier H, Fuchs B, Otto F, et al. (2001) Prognostic immunohistochemical markers of primary human melanomas. Br J Dermatol 145:203-209
20. Kristiansen G, Yu Y, Schluns K, et al. (2003) Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol 25:77-81
21. Skolarikos A, Alivizatos G, Laguna P, et al. (2007) A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 51:1490-1500
22. Lam JS, Leppert JT, Figlin RA, et al. (2005) Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6:7-18
23. Chin AI, Lam JS, Figlin RA, et al. (2006) Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol 8:1-7